These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 347205)
1. Antibody activity against Mycobacterium leprae antigen 7 during the first year of DDS treatment in lepromatous (BL-LL) leprosy. Melsom R; Naafs B; Harboe M; Closs O Lepr Rev; 1978 Mar; 49(1):17-29. PubMed ID: 347205 [No Abstract] [Full Text] [Related]
2. Class specific anti-Mycobacterium leprae antibody assay in lepromatous leprosy (BL-LL) patients during the first two to four years of DDS treatment. Melsom R; Harboe M; Naafs B Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):271-81. PubMed ID: 6754639 [TBL] [Abstract][Full Text] [Related]
3. Stability of individual antimycobacterial precipitation patterns during treatment for lepromatous leprosy. Bjorvatn B; Naafs B; Kronvall G Int J Lepr Other Mycobact Dis; 1978; 46(2):144-8. PubMed ID: 355156 [TBL] [Abstract][Full Text] [Related]
5. Antibody activity against Mycobacterium leprae antigen 7 in leprosy: studies on variation in antibody content throughout the spectrum and on the effect of DDS treatment and relapse in BT leprosy. Yoder L; Naafs B; Harboe M; Bjune G Lepr Rev; 1979 Jun; 50(2):113-21. PubMed ID: 396427 [No Abstract] [Full Text] [Related]
6. Relation between anti-Mycobacterium leprae antibody activity and clinical features in borderline tuberculoid (BT) leprosy. Touw Langendijk EJ; van Diepen TW; Harboe M; Belehu A Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):305-11. PubMed ID: 6358061 [TBL] [Abstract][Full Text] [Related]
7. Effect of treatment on antibody activity against Mycobacterium leprae antigen 7 in tuberculoid leprosy. Dahle JS; van Diepen TW; Touw Langendijk EJ; Harboe M; Belehu A Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):312-20. PubMed ID: 6358062 [TBL] [Abstract][Full Text] [Related]
8. Detection of phenolic glycolipid I in sera from patients with lepromatous leprosy. Young DB; Harnisch JP; Knight J; Buchanan TM J Infect Dis; 1985 Nov; 152(5):1078-81. PubMed ID: 3900237 [No Abstract] [Full Text] [Related]
9. Serological response in leprosy and tuberculosis patients to the 18-kDa antigen of Mycobacterium leprae and antigen 85B of Mycobacterium bovis BCG. Vikerfors T; Olcén P; Wiker H; Watson JD Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):571-80. PubMed ID: 8151188 [TBL] [Abstract][Full Text] [Related]
10. Antigens of Mycobacterium leprae identified by immunoprecipitation with sera from leprosy and tuberculosis patients. Britton WJ; Hellqvist L; Garsia RJ; Basten A Clin Exp Immunol; 1988 Mar; 71(3):394-8. PubMed ID: 3289801 [TBL] [Abstract][Full Text] [Related]
11. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. Mustafa AS Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259 [TBL] [Abstract][Full Text] [Related]
12. PGL-I antigen and antibody detection in leprosy patients: evolution under chemotherapy. Chanteau S; Cartel JL; Celerier P; Plichart R; Desforges S; Roux J Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):735-43. PubMed ID: 2681456 [TBL] [Abstract][Full Text] [Related]
13. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants. Reitan LJ; Closs O; Belehu A Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003 [TBL] [Abstract][Full Text] [Related]
14. Analysis of circulating immune complexes from leprosy patients for Mycobacterium leprae antigens. Sinha S; Chaturvedi V; Mishra B; Sengupta U Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):396-403. PubMed ID: 1282143 [TBL] [Abstract][Full Text] [Related]
15. Class-specific immunoglobulins and antibodies to mycobacterial sonicates and autoantigens in leprosy patients and contacts. Mathew JM; Muthukkaruppan V Microb Pathog; 1993 Nov; 15(5):367-76. PubMed ID: 8015417 [TBL] [Abstract][Full Text] [Related]
16. Effects of chemotherapy on antibody levels directed against PGL-I and 85A and 85B protein antigens in lepromatous patients. Drowart A; Chanteau S; Huygen K; De Cock M; Cartel JL; De Bruyn J; Launois P; Yernault JC; Van Vooren JP Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):29-34. PubMed ID: 8326178 [TBL] [Abstract][Full Text] [Related]
17. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy. Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769 [TBL] [Abstract][Full Text] [Related]
18. Immunological reactions to mycobacterial proteins in the spectrum of leprosy. Rada EM; Aranzazu N; Convit J Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):497-500. PubMed ID: 9465162 [No Abstract] [Full Text] [Related]
19. The use of subcellular components of BCG for studying host-Mycobacterium interaction in relation to leprosy. Das PK; Ibrahim AA; Binkhuysen F; Thi Hué P; Qui TH; Rangarajan R; Ruitenberg EJ Ann Immunol (Paris); 1982; 133D(1):41-59. PubMed ID: 6760793 [No Abstract] [Full Text] [Related]
20. Demonstration of antibodies reacting with different determinants on Mycobacterium leprae antigen 7. Harboe M; Closs O; Reitan LJ; Draper P Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):147-58. PubMed ID: 6168595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]